BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 33032902)

  • 61. Clinical and molecular classification of vulvar squamous pre-cancers.
    Cohen PA; Anderson L; Eva L; Scurry J
    Int J Gynecol Cancer; 2019 May; 29(4):821-828. PubMed ID: 30737358
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Decreased survival in EGFR gene amplified vulvar carcinoma.
    Growdon WB; Boisvert SL; Akhavanfard S; Oliva E; Dias-Santagata DC; Kojiro S; Horowitz NS; Iafrate AJ; Borger DR; Rueda BR
    Gynecol Oncol; 2008 Nov; 111(2):289-97. PubMed ID: 18768215
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumor cell-specific Serpin A1 expression in vulvar squamous cell carcinoma.
    Lagerstedt M; Huotari-Orava R; Nyberg R; Nissinen L; Farshchian M; Laasanen SL; Snellman E; Mäenpää JU; Kähäri VM
    Arch Gynecol Obstet; 2019 May; 299(5):1345-1351. PubMed ID: 30607583
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The immune microenvironment in vulvar (pre)cancer: review of literature and implications for immunotherapy.
    Abdulrahman Z; Kortekaas KE; De Vos Van Steenwijk PJ; Van Der Burg SH; Van Poelgeest MI
    Expert Opin Biol Ther; 2018 Dec; 18(12):1223-1233. PubMed ID: 30373410
    [TBL] [Abstract][Full Text] [Related]  

  • 65. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
    Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
    Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prognostication of vulvar cancer based on p14ARF status: molecular assessment of transcript and protein.
    Lavorato-Rocha AM; de Melo Maia B; Rodrigues IS; Stiepcich MM; Baiocchi G; da Silva Cestari FM; Carvalho KC; Soares FA; Rocha RM
    Ann Surg Oncol; 2013 Jan; 20(1):31-9. PubMed ID: 22878614
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinoma.
    Salama AM; Momeni-Boroujeni A; Vanderbilt C; Ladanyi M; Soslow R
    Mod Pathol; 2022 Feb; 35(2):274-282. PubMed ID: 34650187
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prognostic Significance of Human Papilloma Virus and p16 Expression in Patients with Vulvar Squamous Cell Carcinoma who Received Radiotherapy.
    Yap ML; Allo G; Cuartero J; Pintilie M; Kamel-Reid S; Murphy J; Mackay H; Clarke B; Fyles A; Milosevic M
    Clin Oncol (R Coll Radiol); 2018 Apr; 30(4):254-261. PubMed ID: 29449057
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique.
    Thompson EF; Hoang L; Höhn AK; Palicelli A; Talia KL; Tchrakian N; Senz J; Rusike R; Jordan S; Jamieson A; Huvila J; McAlpine JN; Gilks CB; Höckel M; Singh N; Horn LC
    Int J Gynecol Cancer; 2022 Aug; 32(8):977-985. PubMed ID: 35764349
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Differentiated vulvar intraepithelial neoplasia long-term follow up and prognostic factors: An analysis of a large historical cohort.
    Gallio N; Preti M; Jones RW; Borella F; Woelber L; Bertero L; Urru S; Micheletti L; Zamagni F; Bevilacqua F; Tondo P; Pollano B; Cassoni P; Benedetto C
    Acta Obstet Gynecol Scand; 2024 Jun; 103(6):1175-1182. PubMed ID: 38383115
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Immune Checkpoint Inhibitor LAG-3 and Its Ligand GAL-3 in Vulvar Squamous Neoplasia.
    Cocks MM; Mills AM
    Int J Gynecol Pathol; 2022 Mar; 41(2):113-121. PubMed ID: 33782343
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
    Kashofer K; Regauer S
    Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
    [TBL] [Abstract][Full Text] [Related]  

  • 73. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.
    Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E
    Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182
    [TBL] [Abstract][Full Text] [Related]  

  • 74. p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas.
    Kim YT; Thomas NF; Kessis TD; Wilkinson EJ; Hedrick L; Cho KR
    Hum Pathol; 1996 Apr; 27(4):389-95. PubMed ID: 8617483
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Spectrum of HPV-independent Penile Intraepithelial Neoplasia: A Proposal for Subclassification.
    Regauer S; Ermakov M; Kashofer K
    Am J Surg Pathol; 2023 Dec; 47(12):1449-1460. PubMed ID: 37768009
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HPV-positive clinically advanced squamous cell carcinoma of the urinary bladder (aBSCC): A comprehensive genomic profiling (CGP) study.
    Ghelani GH; Zerdan MB; Jacob J; Spiess PE; Li R; Necchi A; Grivas P; Kamat A; Danziger N; Lin D; Huang R; Decker B; Sokol ES; Cheng L; Pavlick D; Ross JS; Bratslavsky G; Basnet A
    Urol Oncol; 2023 Dec; 41(12):486.e15-486.e23. PubMed ID: 37821306
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevalence and type distribution of human papillomavirus infections in Danish patients diagnosed with vulvar squamous cell tumors and precursors.
    Brusen Villadsen A; Bundgaard-Nielsen C; Ambühl L; Tang Svendsen M; Søkilde Pedersen I; Stæhr Hansen E; Baandrup U; Blaakær J; Sørensen S
    Gynecol Oncol Rep; 2021 Aug; 37():100828. PubMed ID: 34621943
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma.
    Proctor L; Hoang L; Moore J; Thompson E; Leung S; Natesan D; Chino J; Gilks B; McAlpine JN
    Int J Gynecol Cancer; 2020 Jan; 30(1):100-106. PubMed ID: 31771962
    [TBL] [Abstract][Full Text] [Related]  

  • 79. p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias.
    Riethdorf S; Neffen EF; Cviko A; Löning T; Crum CP; Riethdorf L
    Hum Pathol; 2004 Dec; 35(12):1477-83. PubMed ID: 15619206
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MALDI Mass Spectrometry Imaging Reveals Decreased CK5 Levels in Vulvar Squamous Cell Carcinomas Compared to the Precursor Lesion Differentiated Vulvar Intraepithelial Neoplasia.
    Zhang C; Arentz G; Winderbaum L; Lokman NA; Klingler-Hoffmann M; Mittal P; Carter C; Oehler MK; Hoffmann P
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.